Please note: From 21st December 2024 – 1st January 2025 the Membershipservice will be closed. During this time, no inquiries will be processed. We will be back for you from 2nd January 2025.
By decision of the General Assembly of 24th October 2018 in Nantes, the implementation of an organized membership survey in all member countries should be conducted.
In this survey, the possible goals and obstacles in the context of future development within the societies and thus also the Oncology Pharmacy should be surveyed and compiled at the end of the year in an overall report. A report about the results was published in EJOP (EJOP. 6(1):e00043, January-March 2023.)
ESOP is asking again. We encourage everyone to fill out this questionnaire again, because we want to know whether COVID and other crises have changed the goals and ideas about the future of oncology pharmacy.
Deadline 31st December 2024
Members use the “Yellow Hand”
For 10 years we have been calling on all pharmaceutical companies to use the “Yellow Hand” as a label when shipping cancer drugs, in order to encourage the proper handling of these drugs during transport and delivery.
In order to set a good example of safe supply, many pharmacies use the “Yellow Hand” to label transport containers in which the individually prepared drug solutions or syringes are brought internally to the place of administration.
Today we want to present a special award to all those members who send us a photo of the use of the “Yellow Hand” in their work area.
This award will be presented for the first time at ECOP 6 in Lisbon and subsequently at the respective national conferences of our member societies.
In the following is an example of the use of the “Yellow Hand” that we took at my place of work some time ago.
I ask all members to send their photo to the membership service by September 7th so that we can prepare the award ceremony early.
Klaus Meier
ESOP President
ESOP supports the worldwide Petition
ESOP – the world’s largest multinational oncology pharmacy society,
supporting the interests of cancer patients.
Become a member
